Cargando…

Role of Environmental Confounding in the Association between FKBP5 and First-Episode Psychosis

Background: Failure to account for the etiological diversity that typically occurs in psychiatric cohorts may increase the potential for confounding as a proportion of genetic variance will be specific to exposures that have varying distributions in cases. This study investigated whether minimizing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ajnakina, Olesya, Borges, Susana, Di Forti, Marta, Patel, Yogen, Xu, Xiaohui, Green, Priscilla, Stilo, Simona A., Kolliakou, Anna, Sood, Poonam, Marques, Tiago Reis, David, Anthony S., Prata, Diana, Dazzan, Paola, Powell, John, Pariante, Carmine, Mondelli, Valeria, Morgan, Craig, Murray, Robin M., Fisher, Helen L., Iyegbe, Conrad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101879/ https://www.ncbi.nlm.nih.gov/pubmed/25101008 http://dx.doi.org/10.3389/fpsyt.2014.00084

Ejemplares similares

T130. ASSOCIATIONS BETWEEN DIFFERENT TYPES OF CHILDHOOD ADVERSITY AND 5-YEAR OUTCOMES IN FIRST-EPISODE PSYCHOSIS PATIENTS
por: Ajnakina, Olesya, et al.
Publicado: (2018)

Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study
por: Ajnakina, Olesya, et al.
Publicado: (2017)

T14. ASSESSING DIFFERENCES IN INFLAMMATORY MARKERS BETWEEN FIRST EPISODE PSYCHOSIS PATIENTS AND HEALTHY CONTROLS: THE IMPORTANCE OF CONTROLLING FOR CONFOUNDING FACTORS
por: Giordano, Annalisa, et al.
Publicado: (2018)

Differential gene expression analysis in blood of first episode psychosis patients
por: Leirer, Daniel J., et al.
Publicado: (2019)

O8.7. COGNITIVE SUBTYPES IN FIRST-EPISODE PSYCHOSIS AND ASSOCIATION TO TREATMENT RESPONSE
por: Russo, Manuela, et al.
Publicado: (2018)

Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode Psychoses
por: Ajnakina, Olesya, et al.
Publicado: (2021)

Serum and gene expression profile of cytokines in first-episode psychosis
por: Di Nicola, Marco, et al.
Publicado: (2013)

O4.5. INVESTIGATING GENETIC PROFILES ASSOCIATED WITH ‘REAL WORLD’ CLINICAL OUTCOMES IN PSYCHOSIS: A RETROSPECTIVE COHORT STUDY
por: Francis, Emma, et al.
Publicado: (2018)

F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY
por: Rodriguez, Victoria, et al.
Publicado: (2018)

Familial risk and childhood adversity interplay in the onset of psychosis
por: Trotta, Antonella, et al.
Publicado: (2015)

A Systematic Review of Cognitive Function in First-Episode Psychosis, Including a Discussion on Childhood Trauma, Stress, and Inflammation
por: Aas, Monica, et al.
Publicado: (2014)

Social Disadvantage: Cause or Consequence of Impending Psychosis?
por: Stilo, Simona A., et al.
Publicado: (2013)

Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
por: Mondelli, Valeria, et al.
Publicado: (2015)

The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
por: Kose, Melisa, et al.
Publicado: (2021)

Further evidence of a cumulative effect of social disadvantage on risk of psychosis
por: Stilo, S. A., et al.
Publicado: (2017)

Does environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis?
por: Iyegbe, Conrad O, et al.
Publicado: (2015)

S186. THE EFFECTS OF CHILDHOOD TRAUMA ON HIPPOCAMPAL VOLUME IN FIRST EPISODE PSYCHOSIS: DOES CORTISOL PLAY A ROLE?
por: Ciufolini, Simone, et al.
Publicado: (2020)

White matter integrity as a predictor of response to treatment in first episode psychosis
por: Reis Marques, Tiago, et al.
Publicado: (2014)

A comparison between self-report and interviewer-rated retrospective reports of childhood abuse among individuals with first-episode psychosis and population-based controls
por: Gayer-Anderson, Charlotte, et al.
Publicado: (2020)

Neuroactive Steroids in First-Episode Psychosis: A Role for Progesterone?
por: Belvederi Murri, Martino, et al.
Publicado: (2016)

Impact of Different Childhood Adversities on 1-Year Outcomes of Psychotic Disorder in the Genetics and Psychosis Study
por: Trotta, Antonella, et al.
Publicado: (2016)

Can cognitive insight predict symptom remission in a first episode psychosis cohort?
por: O’Connor, Jennifer A., et al.
Publicado: (2017)

Investigation of the glucocorticoid receptor co-chaperone FKBP5 in individuals with first-episode psychosis
por: Theodoridou, D., et al.
Publicado: (2021)

Only a small proportion of patients with first episode psychosis come via prodromal services: a retrospective survey of a large UK mental health programme
por: Ajnakina, Olesya, et al.
Publicado: (2017)

Globally Efficient Brain Organization and Treatment Response in Psychosis: A Connectomic Study of Gyrification
por: Palaniyappan, Lena, et al.
Publicado: (2016)

Complement system biomarkers in first episode psychosis
por: Kopczynska, Maja, et al.
Publicado: (2019)

Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis
por: Pollak, Thomas A., et al.
Publicado: (2021)

Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study
por: Gaughran, Fiona, et al.
Publicado: (2019)

Prevention of psychosis: moving on from the at-risk mental state to universal primary prevention
por: Murray, Robin M., et al.
Publicado: (2021)

S24. IS IT FEASIBLE TO PREDICT LONG-TERM METABOLIC OUTCOMES IN PSYCHOSIS USING BIOLOGICAL PROFILING AT BASELINE?
por: Iyegbe, Conrad, et al.
Publicado: (2018)

35.1 ONLY A SMALL PROPORTION OF PATIENTS WITH FIRST EPISODE PSYCHOSIS COME VIA PRODROMAL SERVICES: A RETROSPECTIVE SURVEY OF A LARGE UK MENTAL HEALTH PROGRAMME
por: Ajnakina, Olesya, et al.
Publicado: (2018)

30.1 IMMUNE PATHOGENESIS OF PSYCHOSIS: THE CHALLENGE OF CO-MORBIDITY
por: Upthegrove, Rachel, et al.
Publicado: (2018)

35.4 A PUBLIC HEALTH APPROACH TO THE PREVENTION OF PSYCHOSIS
por: Murray, Robin, et al.
Publicado: (2018)

Study protocol for the development and internal validation of Schizophrenia Prediction of Resistance to Treatment (SPIRIT): a clinical tool for predicting risk of treatment resistance to antipsychotics in first-episode schizophrenia
por: Farooq, Saeed, et al.
Publicado: (2022)

What can neuroimmunology teach us about the symptoms of long-COVID?
por: Mondelli, Valeria, et al.
Publicado: (2021)

Recorded poor insight as a predictor of service use outcomes: cohort study of patients with first-episode psychosis in a large mental healthcare database
por: Ramu, Neha, et al.
Publicado: (2019)

Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case–control study
por: Colizzi, Marco, et al.
Publicado: (2015)

T183. LOW LEVELS OF VITAMIN D ARE ASSOCIATED WITH REDUCED CORTICAL THICKNESS AND SURFACE AREA IN FRONTAL, TEMPORAL AND OCCIPITAL REGIONS IN FIRST-EPISODE PSYCHOSIS PATIENTS
por: Ciufolini, Simone, et al.
Publicado: (2020)

T104. ASSESSING THE UTILITY OF COPULA FUNCTIONS FOR RISK PREDICTION OF PSYCHOSIS
por: Zhang, Landan, et al.
Publicado: (2018)

Threatening Life Events and Difficulties and Psychotic Disorder
por: Beards, Stephanie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gu4lq7t8uebh962lt0v831cp6r